AnaptysBio, Inc.

AnaptysBio, Inc. financial statements

AnaptysBio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 234.6M10-KT
Net income−USD 13.23M10-KT
Cash and equivalentsUSD 138.2M10-KT
Total debtUSD 14.11MEODHD

AnaptysBio, Inc. financials on 6ix · AnaptysBio, Inc. on 6ix